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Abstract 
Objective  
Evidence-based information about adverse birth outcomes and pregnancy complications is 
crucial when counselling women with coeliac disease (CD), however, limited population-
based data on such risks exist. We estimated these for pregnant women with CD diagnosed 
before and after delivery. 
 
Design 
We included all singleton pregnancies between 1997-2012 using linked primary care data 
from the Clinical Practice Research Datalink (CPRD) and secondary care Hospital Episode 
Statistics (HES) data. Risks of pregnancy complications (antepartum and postpartum 
haemorrhage, pre-eclampsia and mode of delivery) and adverse birth outcomes (preterm 
birth, stillbirth and low birth weight) were compared between pregnancies of women with 
and without CD using logistic/multinomial regression. Risks were stratified based on whether 
women were diagnosed or yet undiagnosed before delivery.  
 
Results  
Of 363,930 pregnancies resulting in a live birth or stillbirth, 892 (0.25%) were among women 
with CD. Diagnosed CD was not associated with an increased risk of pregnancy 
complications or adverse birth outcomes compared to women without CD. However, the risk 
of postpartum haemorrhage was slightly higher among pregnant women with diagnosed CD 
(adjusted Odds Ratio (aOR)=1.34 95%CI;1.04-1.72). We found no increased risk of any 
pregnancy complication among those with undiagnosed CD. We only observed 1% absolute 
excess risk of pre-term birth and low birth weight among undiagnosed CD mothers 
corresponding to aOR=1.24 (95%CI;0.82-1.87) and aOR=1.36 (95%CI;0.83-2.24) 
respectively. 
 
Conclusion 
Whether diagnosed or undiagnosed during pregnancy, CD is not associated with a major 
increased risk of pregnancy complications and adverse birth outcomes. These findings are 
reassuring to both women and clinicians.   
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What is current knowledge? 
 About 10 in 1000 pregnant women could have some form of latent or undetected CD 
and that about 2 in 1000 deliveries per year in the UK will be in women with known 
coeliac disease.   
 There is lack of evidence on the risk of pregnancy complications among women with 
CD 
 Most studies done on the subject often suffer from either selection bias or inadequate 
power which limits the generalisability of the study findings.  
 
What is new here? 
 Most women with CD diagnosed either before or after pregnancy will have a 
pregnancy and delivery that is not complicated by an adverse event.     
 Women with diagnosed with CD may have a slightly increased risk of postpartum 
haemorrhage but the reasons for this are not clear.  
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Introduction  
Subclinical pathological evidence of coeliac disease (CD) is present in around 1% of most 
European populations(1) of which approximately 0.2% have been clinically diagnosed with 
CD.(2) This suggests that about 10 in 1000 pregnant women could have some form of latent 
or undetected CD and that about 2 in 1000 deliveries per year in the UK will be in women 
with known CD.  Given this estimated prevalence and the potential adverse physiological 
effects CD might engender it is surprising that so few good studies have been produced that 
have tried to quantify the risks to the mother and the child around delivery.  The studies(3-9) 
that have tried to quantify the risks of pregnancy and delivery related adverse events among 
women with CD can be categorised broadly as either case-series of individuals, in single or 
multiple centres pooled together, or registry-based.  Most case-series(4, 10, 11) have been 
based on a small number of pregnant women with known CD (i.e. <150) or pregnant women 
who are screened for positive serology leading to the identification of a small number of 
women with previously undiagnosed CD.  Unsurprisingly the results are conflicting; for 
example Martinelli et al(11) reported that the 12 pregnant women they found to have 
undiagnosed CD were more likely to have babies with low birth weight compared to those 
who were serology negative; however, a similar study based on 52 undiagnosed cases from 
multiple centres found no excess risk of low birth in offspring.(10)  Far larger studies from 
Sweden and Denmark,(7, 8) have used in-patient national registries to identify women with 
CD which provide greater number of women, however, appear to underestimate the 
prevalence of CD.  This may explain their findings of an increased risk of some adverse birth 
outcomes for both mother (caesarean section) and child (low birth weight, intrauterine growth 
restriction)(7, 8) if the populations they have studied were not generalisable to all women 
with CD. 
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It appears therefore that accurate contemporary estimates of the risk of adverse birth 
outcomes among women with undiagnosed and diagnosed CD that are generalisable to the 
majority are absent.  We have carried out a population-based cohort study using primary and 
secondary healthcare data from England with the aim of quantifying the risks of pregnancy 
complications and adverse birth outcomes among women with CD.  
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Methods 
Study population  
We used the Clinical Practice Research Datalink (CPRD) (12) which is a large longitudinal 
UK database of computerised primary care (i.e. general practice) records. The vast majority 
of the UK population is registered with general practitioners (GPs), who are responsible for 
overseeing a patient’s medical care which includes coordination of their health care from 
hospital or other secondary care facilities. The CPRD includes practices that have met 
training standards in their recording of clinical information using Vision software and who 
have consented to be included in the database.(13) All patients within a consented practice 
are automatically included.  
 
Around 53% of the CPRD practices are linked to Hospital Episode Statistics (HES)(14) data 
which contain information on all hospitalisations in England including all discharge 
diagnoses and procedures. The anonymised patient identifiers from CPRD and HES were 
linked by a trusted third party using the National Health Service (NHS) number, date of birth, 
postcode and gender.(15) First, patients were matched exactly according to the NHS number 
(over 90% of patients are linked in this way), with the remaining patients linked 
probabilistically on the basis of postcode, date of birth and gender  As HES only covers 
English hospitals, practices from Northern Ireland, Wales and Scotland were excluded. 
Previously, data from the linked portion of the CPRD have been shown to be broadly 
representative in terms of age and sex distribution to data from the UK population published 
by the Office for National Statistics (ONS).(16) We identified all singleton pregnancies 
recorded in HES between 1997 and 2012 that ended in a live birth or a stillbirth among 
women aged 15-44 years as our study population. We therefore had prospectively recorded 
health and socio-demographic information for women before, during and after pregnancy.  
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Mothers with CD were defined as those with a medical Read code for a diagnosis of CD in 
their primary care records (including Read code J690.00 CD, J690.13 Gluten enteropathy, 
J690.14 Sprue-nontropical, J690100 Acquired CD and J690z00 CD NOS). We did not 
include women who had diagnoses of dermatitis herpetiformis (DH), however, women with 
both diagnoses (CD and DH) were retained in the CD group. Each woman with CD was 
assigned a date of diagnosis corresponding to the date of her first record of CD or the date of 
her first prescription of a gluten-free product. These women were then classified as having 
the CD diagnosis before delivery (diagnosed CD) or afterwards (undiagnosed CD) for each 
pregnancy in the study. Pregnancies among women with a recorded history of CD prior to the 
study start date were included in the diagnosed CD group. The method we used for defining 
CD has been validated in general practice databases with the positive predictive value 
ranging between 81% and 89%.(2)  
 
Pregnancies where women’s first diagnosis of CD was recorded in the 12 weeks postpartum 
were also included in the diagnosed CD group.  We used this conservative approach firstly to 
include women who may have had well-controlled CD not requiring medical/GP contact 
before or during pregnancy but whose postpartum follow-up may have resulted in a recorded 
diagnosis; and secondly the diagnostic work-up/process for CD may be long and therefore 
these are unlikely to be new diagnoses. 
 
Our comparison group consisted of pregnant women without any recorded diagnoses of CD 
or DH in their primary or secondary care data. Pregnant women who received a gluten-free 
prescription in the absence of any CD or DH diagnosis at any point during the study period 
were also excluded.  
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Defining outcomes  
We extracted information on pregnancy complications which included postpartum 
haemorrhage, antepartum haemorrhage and pre-eclampsia/eclampsia based on ICD-10 codes 
from secondary care. Mode of delivery was categorised as normal vaginal delivery, assisted 
vaginal delivery (forceps, breech or vaccuum), emergency or elective caesarean section.  
Information on length of gestation was categorised as normal (37-42 weeks), pre term (<37 
weeks) or prolonged (>42 weeks) whereas infant’s birth weight was categorised as normal 
(2500-4500 grams), low birth weight (>2500 grams) or macrosomia (<4500 grams). We also 
analysed birth weight as a continuous variable. Finally we also extracted information on 
pregnancies resulting in stillbirths.  
 
Defining maternal co-variables 
For each pregnancy, information on maternal factors during or before pregnancy was 
extracted from the women’s medical records. Maternal age at delivery was categorised into 
six age groups (15-19, 20-24, 25-29, 30-34, 35-39 and 40-44 years) whereas calendar year 
was considered in three   categories (1997-2001, 2002-2007 and 2007-2012). Information on 
body mass index (BMI) (the latest measure recorded by the general practitioner before the 
estimated date of conception categorised according to World Heath Organisation 
classification), smoking status (the latest measure recorded by the GP before delivery) and 
ethnicity (as recorded in HES and categorised as white or non-white(17)) was also extracted.  
Socioeconomic status (SES) defined as the area in which the general practice is located, at 
which the patient was registered (quintiles by rank of Indices of Multiple Deprivation(18)). 
Pregnant women were also defined as having diabetes (pre-existing type 1 or type 2) if it was 
recorded either in primary or secondary care data, or they had received a prescription for an 
anti-diabetic medication (insulin or oral hypoglycaemic agents) any time before delivery.  
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Statistical analysis 
We calculated the proportions of pregnancies with complications or adverse birth outcomes 
that occurred in women with and without a diagnosis of CD.  These proportions were then 
stratified by the status of the pregnancy with respect to having diagnosed or undiagnosed CD. 
We used logistic regression to calculate odds ratios (OR) and 95% Confidence Intervals (95% 
CI) to assess the associations of CD overall, diagnosed CD and undiagnosed CD with each 
pregnancy complication and adverse birth outcome. For categorical outcomes (e.g. mode of 
delivery), multinomial logistic regression was used and relative risk ratios (RRRs) and 
corresponding 95% CIs were calculated. These estimates were adjusted for all potential 
confounders: maternal age, BMI, smoking status, diabetes, ethnicity, calendar year and 
socioeconomic status. Missing information on BMI, smoking status and birth weight was 
categorised as a separate category and included in the analysis. We used linear regression to 
calculate the mean grams of difference in the birth weight of infants born to women with CD 
compared with those born to women without CD while adjusting for all co-variables. As 
some women experienced more than one pregnancy during the study period, a clustering term 
(in our regression models) was fitted.  For the purpose of this study, we only considered 
pregnancy complication or adverse birth outcome to be truly associated with CD if we 
observed an absolute risk difference (between women with and without CD) of 3% or more. 
All outcomes with the absolute risk difference of less than 3% where considered to be within 
the random variation of the data. 
 
Sensitivity analyses  
We undertook four additional analyses to ensure the robustness of our results. Firstly, we 
repeated our analysis by restricting the group of women with CD to only those who had 
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received a gluten-free prescription to increase the specificity of our disease definition. 
Secondly, we assessed the extent to which women had only hospital recordings of CD using 
ICD-10 codes (K90.0) (with no evidence in their primary care records) and repeated our 
analysis including these cases. We also repeated our analyses reclassifying those pregnancies 
in women who had their diagnosis recorded for the first time within the 12 weeks postpartum 
as undiagnosed CD (rather than diagnosed). Finally, we assessed whether there is an 
independent increase in the risk of adverse birth outcomes regardless of the mode of delivery. 
This was done by restricting our analysis to only those women who underwent a normal 
vaginal delivery.  All analyses were carried out using Stata SE 11.2 (Stata Corp., TX, USA).  
 
Ethical statement  
This study was approved by the Independent Scientific Advisory Committee (ISAC) 
reference number=10_193R. 
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Results  
Study population  
Among 276,586 women in our study population, there were 364,186 singleton pregnancies 
resulting in a live birth or a stillbirth. We excluded 0.07% (n=256) of pregnancies in women 
with DH without CD (0.01%) or who had gluten-free prescriptions without any evidence of 
concurrent CD (0.05%). This resulted in a total of 363,930 pregnancies which were included 
in the analysis.  The overall proportion of pregnancies among women with CD was 0.25% 
(892/363,930) with the median age at diagnosis of 29 years (inter quartile range 20.2-34.7).. 
Of these pregnancies 62% (n=551) were among women with diagnosed CD and 38% (n=341) 
among women with undiagnosed CD. Table 1 shows the maternal characteristics for all 
pregnancies in women with and without CD. Compared to women without CD, women with 
CD had lower BMI, were less likely to be smokers and had a higher prevalence of diabetes. 
Pregnant women with diagnosed CD were slightly older than those with undiagnosed CD but 
otherwise had similar maternal characteristics.  
 
Pregnancy complications and adverse birth outcomes among women with CD 
Table 2 shows the absolute risks of pregnancy complications and adverse birth outcomes 
among pregnancies in women with diagnosed and undiagnosed CD and those in women 
without CD. Overall, pregnancies in women with CD had slightly higher incidence of 
postpartum and antepartum haemorrhage, peeclampsia/eclampsia, caesarean section delivery, 
assisted delivery, stillbirth, preterm birth or low birth weight babies compared to pregnant 
women without CD (absolute risk difference of <2.5%), all of which were not statistically 
significant.  
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Diagnosed coeliac disease 
Among pregnancies in women diagnosed with CD, we found a slightly higher risk of 
postpartum haemorrhage with an absolute risk (AR) of 13.2% (Table 2) than women without 
CD. This corresponded to a 3.5% excess absolute risk and a 34% increased adjusted relative 
risk (OR 1.34 (95% CI 1.04-1.72 compared to pregnancies in women without CD (Table 3). 
There was no statistically significant increased risk of pre-eclampsia/eclampsia, antepartum 
haemorrhage or caesarean section delivery. We observed a greater risk of assisted deliveries 
among those with diagnosed coeliac disease (AR=15% versus 12% in women without CD) 
which corresponded to a 34% increased relative risk (Adjusted OR (aOR) 1.34, 95% CI: 
1.05-1.71) and 3% excess absolute risk. The risk of stillbirth, preterm birth and babies born 
with low birth weight was similar among pregnancies in women with diagnosed CD and 
without CD. Finally, there was no mean difference in the birth weight of babies born to 
women with diagnosed CD compared to women without CD (Adjusted mean difference = -15 
grams 95%CI -72 grams to 41 grams).   
 
Undiagnosed coeliac disease 
Among pregnancies in women with undiagnosed coeliac disease, we found no overall 
increased risk of postpartum haemorrhage, pre-eclampsia/eclampsia, antepartum 
haemorrhage or having an assisted delivery or emergency caesarean section (Tables 2 and 3). 
Compared to pregnancies among women without CD, the risk of preterm birth was roughly 
similar among those with undiagnosed coeliac disease (6.5% versus 7.6%) (aOR=1.24 
95%CI 0.82-1.88). We found that pregnancies in women with undiagnosed CD resulted in 
babies with a mean birth weight 65 grams lower than babies born to women without CD, 
however, this difference was not statistically significant at the 5% level (95% CI -151grams 
to 20 grams) after adjusting for all potential confounding factors.  
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Sensitivity and other analyses 
Sixty seven percent of pregnant women with CD received a gluten-free prescription during 
the study period. Our findings for both diagnosed and undiagnosed CD remained broadly 
consistent when we added coeliac cases recorded solely in the secondary care data (n=176) 
and restricted our analysis to only those cases who received a gluten-free prescription 
(n=595) (Table 4). However we did find a statistically significant increased risk of infants 
with low birth weight born to mothers with CD compared to those without CD. (aOR=1.83 
95%CI 1.05-3.17). When we included pregnancies in women with CD that had been 
classified as diagnosed due to their diagnosis being in the postpartum period as undiagnosed, 
our risk estimates remained unchanged (Table 5). Similarly our estimates for pregnancy 
complications and adverse birth outcomes remained unchanged when we restricted our 
analysis to pregnant women who underwent normal vaginal delivery (Table 5). This was with 
the exception of postpartum haemorrhage which was not associated with increased risk 
among women with diagnosed CD. 
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Discussion  
Main findings 
In this large nationally representative cohort of more than 360,000 singleton pregnancies 
resulting in a live birth or a stillbirth, we have provided contemporary, generalisable, 
population-based estimates of the proportion of pregnancies in England that occur in women 
either with a diagnosis of CD prior to delivery or following it and their risk of pregnancy 
complications and adverse birth outcomes. We found that 0.25% of pregnancies were among 
women who had or went on to develop CD, of which over one-third are not diagnosed until 
after delivery. With the exception of postpartum haemorrhage and assisted delivery we 
observed no increased risk of pregnancy associated complications or adverse birth outcomes 
among the pregnancies in women with diagnosed CD compared to those without the 
diagnosis. Similarly, we also found that undiagnosed CD is not associated with pregnancy 
complications and adverse birth outcomes.   
 
Strength and limitations  
We have conducted one of the largest studies to determine the risk of pregnancy 
complications and adverse birth outcomes in CD utilising data from both primary and 
secondary care whilst adjusting for important confounding factors such as BMI, smoking 
status and maternal diabetes. Our study used an open cohort approach, with prospectively 
collected data from across England covering 3% of the total UK population with a similar age 
and sex distribution to the population as a whole.  Furthermore, HES is the primary source of 
maternity statistics in England where birth outcomes have been externally validated with high 
accuracy.(19)  This makes our study findings not only generalisable to the singleton 
pregnancies resulting in a live birth or a stillbirth in England but also to other developed 
nations with similar health care systems.  
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Since we used anonymised patient records and had no direct access to the patients, we were 
dependent on the GPs entering data accurately in the CPRD for our case validity.  This is a 
weakness of our study as by being able to use only the available data we the lack of 
histological and serological information common to cohorts that have been studied in specific 
secondary or tertiary centres or with complete linkages to pathology systems.  However 
because the definition of CD we have used is based on recording of a clinical diagnosis by 
the GPs it reflects the real world of clinical practice as it occurs in the general population of 
the UK.  This, in turn, has allowed us to study a large number of pregnancies which would 
not otherwise be easily possible in a bespoke cohort study. Fortunately, this method of 
defining CD has been validated in general practice databases with a positive predictive value 
ranging between 81% and 89% which increases when prescription data are also used.(2) 
When we increased the specificity of our diagnosis by restricting our analysis only to cases 
with a supporting gluten-free prescription, our estimates remained broadly similar for both 
diagnosed and undiagnosed CD indicating that any misclassification inherent to our overall 
definition is likely to have had a small effect on our estimates.  We do acknowledge that CD 
diagnoses recorded in inpatient data in England have not been validated. For this reason we 
only included them in our sensitivity for which our estimates remained unaltered.  
 
It is important to highlight that 33% of pregnant women with CD diagnosis did not receive 
gluten-free prescriptions which may be due to a number of factors. For instance, these 
prescriptions are expensive and aside from during pregnancy/early postpartum (or if other 
comorbidities are present) women of this age do not routinely get free prescriptions in 
England, hence they may purchase specific gluten-free products directly. Moreover, a 
relatively short duration of follow-up (i.e. our inability to capture those prescriptions) and a 
high proportion of “prevalent” cases (i.e. women giving up those prescriptions later on after 
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diagnosis) may also be contributory factors. Another limitation of this study is the lack of 
compliance data on a gluten-free diet among those with diagnosed CD. Like most studies 
done on the topic, we assumed that all women with diagnosed CD are broadly compliant with 
a gluten-free diet which seems reasonable given previous evidence suggesting that complete 
non-adherence to a gluten-free diet is uncommon among patients with CD.(20) There could 
of course be some misclassification in terms of children of mothers with and without CD in 
our study. It is likely that some mothers without CD in our study may have undiagnosed 
disease throughout the whole study period.  This however should only bias our results 
towards the null i.e. of no increase in the risk of pregnancy complications and adverse birth 
outcomes. 
 
We also recognise that our lack of complete data on BMI and birth weight could bias our 
estimates. However, we treated missing data as a separate category and included it in our 
analysis. The fact that we were able to utilise data on BMI does however give us an 
advantage over other studies(3, 7, 8) in this field which have been previously unable to. We 
observed lower proportions of pregnant women with undiagnosed CD in more recent years 
compared to those with diagnosed CD. This was probably due to the fact that in order to be 
undiagnosed, a pregnancy needs to occur earlier in the data and vice versa for those with 
diagnosed CD. Finally, it is important to note that our study may have limited power to show 
small excess risks for certain outcome (e.g. stillbirths). Therefore one cannot rule out minor 
risk increases associated with these outcomes due to a potential for type 2 error. 
 
Comparison with previous literature  
The overall prevalence of CD in our study among pregnant women was calculated to be 
0.25%. Whilst this proportion is much lower than most small scale hospital-based studies 
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(1%),(4, 11) it is not surprising as our cases included those with a clinical diagnosis of CD as 
opposed to positive serology identified via screening. Our proportions are still higher than 
those reported by most large registry-based studies (around 0.07%).(7, 8) This may be due to 
their reliance on in-patient hospital data and lack of out-patient or primary care data leading 
to the under-estimation of the prevalence.  We did not observe increased risks of preterm 
birth and low birth weight among those with diagnosed coeliac disease, a finding consistent 
with the available population based studies.(3, 7, 8, 11) Our finding of a 34% increased risk 
of postpartum haemorrhage and assisted deliveries among those with diagnosed CD is new as 
previous studies have not reported this.  
 
Overall we found no increased risk of low birth weight and preterm birth among undiagnosed 
coeliac mothers. This finding is consistent with a multicentre  study conducted by Greco et 
al.(10) where 5,055 mothers were screened for CD, of which 51(%) had a positive result. The 
study concluded that undiagnosed CD, while common in pregnancy is not associated with an 
excess risk of preterm delivery, low birth weight, abortion or intrauterine growth restriction. 
Our findings do however contradict some of the largest registry based studies to date. (3, 7, 8) 
For instance, Ludvigsson et al(7) in their population-based study demonstrated that women 
with undiagnosed CD were 71% more likely to have preterm birth and over 2-times more 
likely to have infants with low birth weight. These different findings to ours could be because 
the cases identified through hospital-based registers may suffer from a more severe form of 
disease than those diagnosed within the general population.  Our study showed no increased 
risk of caesarean section in the undiagnosed CD group in contrast to an increased risk among 
this group in Swedish data(7). One explanation could be the difference in the medical 
indication and the incidence of caesarean sections in the UK and Sweden (26%(21) versus 
17%(22)).    
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The only persistently increased risk we observed was a 34% increased risk of postpartum 
haemorrhage and assisted deliveries among those with diagnosed CD which has not been 
reported before.  This may be due to the higher proportion of women undergoing assisted 
delivery which may increase the likelihood of postpartum haemorrhage compared with 
normal vaginal delivery.(23) This increased risk in women with diagnosed CD may therefore 
be due to more assisted deliveries rather than disease related per se.  
 
Conclusion and implications 
Most women with CD diagnosed either before or after pregnancy will have a pregnancy and 
delivery that is not complicated by an adverse event.Our findings do suggest that among 
women already diagnosed with CD there may be a small increase in the risk of a pregnancy 
being complicated by a postpartum haemorrhage but the reasons for this are not entirely 
clear.  Overall our results should be reassuring to both women and practitioners. 
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Tables  
Table 1: Basic characteristic of pregnancies among women with and without coeliac disease 
Variables  Without CD 
(Total=363,038) 
With CD  
 (Total=892) 
Diagnosed CD 
(Total=551) 
Undiagnosed CD 
(Total=341) 
 n. % n % n % n % 
Age at delivery         
15-19 years 21,182 5.8 38 4.3 23 4.2 15 4.4 
20-24 years 62,217 17.1 93 10.4 57 10.3 36 10.6 
25-29 Years 95,665 26.4 223 25.0 132 24.0 91 26.7 
30-34 years 110,712 30.5 308 34.5 171 31.0 137 40.2 
35-39 years 60,911 16.8 176 19.7 129 23.4 47 13.8 
40-44 years 12,351 3.4 54 6.1 39 7.1 15 4.4 
         
Body Mass Index kg/m2         
Normal(18.5-24.9) 158,324 43.6 438 49.1 269 48.8 169 49.6 
Underweight(<18.5) 11,802 3.3 63 7.1 39 7.1 24 7.0 
Overweight(25-29.9) 65,726 18.1 137 15.4 94 17.1 43 12.6 
Obese(>=30) 41,109 11.3 74 8.3 40 7.3 34 10.0 
Missing 86,077 23.7 180 20.2 109 19.8 71 20.8 
         
Smoking status         
smoker 79,782 22.0 146 16.4 100 18.1 46 13.5 
Non-smoker 
 
283,256 78.0 746 83.6 451 81.9 295 86.5 
Ethnicity         
White 264,312 72.8 684 76.7 427 77.5 257 75.4 
Non-white 37,148 10.2 55 6.2 30 5.4 25 7.3 
Missing 61,578 17.0 153 17.2 94 17.1 59 17.3 
         
Pre-existing diabetes          
No 359,094 98.9 852 95.5 525 95.3 327 95.9 
Yes 3,944 1.1 40 4.6 26 4.8 14 4.2 
         
Calendar year         
1997-2001 72,837 20.1 204 22.9 81 14.7 123 36.1 
2002-2007 127,055 35.0 321 36.0 171 31.0 150 44.0 
2007-2012 163,146 44.9 367 41.1 299 54.3 68 19.9 
         
SES quintile          
1 (Least deprived) 54,305 15 168 18.8 102 18.5 66 19.4 
2 75,309 20.7 210 23.5 123 22.3 87 25.5 
3 70,955 19.5 178 20.0 111 20.1 67 19.6 
4 83,323 23 179 20.1 106 19.2 73 21.4 
5 (Most deprived) 79,146 21.8 157 17.6 109 19.8 48 14.1 
1Type 1 or type 2 diabetes before conception  
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Table 2: Absolute risks of pregnancy complication and adverse birth outcome among women with 
and without CD. 
Variables Without CD 
(Total=363,038) 
With CD 
Overall 
(Total=892) 
Diagnosed CD 
(Total=551) 
Undiagnosed CD 
(Total=341) 
 n % n % n % n % 
Pregnancy complications          
Postpartum haemorrhage3 35,278 9.7 102 11.4 73 13.2 29 8.5 
Preeclampsia/eclampsia 8,270 2.3 24 2.7 14 2.5 10 2.9 
Antepartum haemorrhage 17,074 4.7 49 5.5 32 5.8 17 5.0 
         
Mode of delivery         
Normal vaginal delivery 233,524 64.3 523 58.6 315 57.2 208 61.0 
Assisted 43,934 12.1 127 14.2 85 15.4 42 12.3 
Elective caesarean 35,443 9.8 107 12.0 61 11.1 46 13.5 
Emergency caesarean 50,137 13.8 135 15.1 90 16.3 45 13.2 
         
Birth outcomes         
Live birth 361,471 99.6 886 99.3 547 99.3 339 99.4 
Stillbirth 1,567 0.4 6 0.7 4 0.7 2 0.6 
         
Length of gestation         
Normal 305,424 84.1 733 82.2 457 82.9 276 80.9 
Pre-term 23,595 6.5 68 7.6 42 7.6 26 7.6 
Prolonged 34,019 9.4 91 10.2 52 9.4 39 11.4 
         
Birth weight         
Live birth (2500-4500 grams) 272,754 75.2 659 73.9 426 77.3 233 68.3 
Macrosomia (above 4500 grams) 5,296 1.5 7 0.8 5 0.9 2 0.6 
Low birth weight < 2500 grams 16,439 4.5 48 5.4 29 5.3 19 5.6 
Missing 68,157 18.8 178 20.0 91 16.5 87 25.5 
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Table 3: Odds ratios of pregnancy complications and adverse birth outcomes among women with 
CD compared to those without CD 
Variables  CD 
Overall  
Diagnosed CD Undiagnosed CD 
 OR (95% CI) 
Adjusted* 
OR (95% CI) 
Adjusted* 
OR (95% CI) 
Adjusted* 
Pregnancy complication     
Postpartum haemorrhage1  1.19 (0.97-1.47) 1.34 (1.04-1.72) 0.94 (0.63-1.40) 
Pre-eclampsia/eclampsia1 1.20 (0.75-1.91) 1.16 (0.65-2.05) 1.25 (0.59-2.76) 
Antepartum haemorrhage1  1.22 (0.92-1.63) 1.28 (0.89-1.83) 1.14 (0.70-1.84) 
    
Mode of delivery2    
Assisted 1.21 (0.99-1.40) 1.34 (1.05-1.71) 1.02 (0.73-1.41) 
Elective caesarean 1.20 (0.95-1.53) 1.10 (0.81-1.40) 1.39 (0.94-2.05) 
Emergency caesarean 1.16 (0.94-1.43) 1.26 (0.98-1.64) 1.00 (0.71-1.42) 
    
Birth outcome    
Stillbirth3 1.59 (0.71-3.54) 1.70 (0.63-4.54) 1.42 (0.35-5.64) 
    
Length of gestation4    
Pre-term 1.17 (0.90-1.53) 1.14 (0.83-1.60) 1.24 (0.82-1.87) 
Prolonged 1.16 (0.92-1.47) 1.08 (0.79-1.47) 1.31 (0.92-1.85) 
    
Birth weight5    
Macrosmia (>4500 grams)  0.52 (0.24-1.09) 0.58 (0.24-1.41) 0.41 (0.10-1.62) 
Low birth weight (<2500 grams) 1.22 (0.89-1.68) 1.15 (0.76-1.74) 1.36 (0.83-2.24) 
Missing  1.07 (0.89-1.29) 0.92 (0.72-1.19) 1.34 (1.00-1.70) 
*Adjusted for smoking status, age, ethnicity, diabetes, BMI, social class and calendar year 
2Multi-nominal regression analysis, risks relative to vaginal delivery 
3Analysis based on live births 
4Multi-nominal regression analysis, analysis based on pregnancies with normal gestational length 
5Multi-nominal regression analysis, analysis based on live births with normal birth weight 
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Table 4: Sensitivity analysis: Risk of pregnancy complications and adverse birth outcomes among women with CD compared to those without CD 
 Restrictive Coeliac definition* 
(Total CD=595) 
Adjusted Odds ratio (95%CI) 
Addition of Coeliac cases from secondary care 
(Total CD=1,068) 
Adjusted Odds ratio (95%CI) 
Variables  Diagnosed CD 
(n=371) 
Undiagnosed CD 
(n=224) 
Diagnosed CD 
(n=604) 
Undiagnosed CD 
(n=464) 
Postpartum haemorrhage1 1.53 (1.14-2.05) 0.89 (0.54-1.46) 1.31 (1.03-1.68) 0.98 (0.64-1.28) 
Pre-eclampsia/eclampsia1 0.85 (0.48-1.78) 1.27 (0.45-3.51) 1.16 (0.67-2.00) 1.23 (0.63-2.40) 
Antepartum haemorrhage1 1.24 (0.80-1.93) 1.11 (0.61-2.02) 1.30 (0.92-1.84) 1.29 (0.87-1.91) 
Assisted delivery2,6 1.24 (0.92-1.69) 0.98 (0.65-1.48) 1.32 (1.04-1.68) 0.96 (0.72-1.28) 
Elective caesarean2,6 1.11 (0.78-1.57) 1.13 (0.68-1.86) 1.13 (0.86-1.50) 1.30 (0.93-1.83) 
Emergency caesarean2,6 1.11 (0.78-1.57) 0.94 (0.61-1.43) 1.24 (0.96-1.59) 0.86 (0.63-1.18) 
Stillbirth3 1.24 (0.31-4.97) 2.11 (0.53-8.35) 1.96 (0.81-4.72) 2.08 (0.78-5.54) 
Pre-term birth4,6 1.12 (0.74-1.69) 1.22 (0.73-2.04) 1.12 (0.81-1.56) 1.31 (0.93-1.84) 
Low birth weight(<2500 grams)5,6 1.03 (0.60-1.74) 1.83 (1.05-3.17) 1.08 (0.81-1.46) 1.50 (1.00-2.24) 
*Coeliac diagnosis with gluten-free prescriptions.  
Adjusted for smoking status, age, ethnicity, diabetes, BMI, social class and calendar year 
1 Analysis based on pregnancy without complication under study  
2Analysis based on normal vaginal delivery 
3Analysis based on live birth 
4Analysis based on normal gestational length 
5Analysis based on live birth with normal weight 
6Results from multi-nominal regression analysis (RRRs, 95% CI) 
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Table 5: Sensitivity analysis: Risk of pregnancy complications and adverse birth outcomes among women with CD compared to those without CD 
 Treating postpartum coeliac as incident case 
(Total CD=892) 
 
Adjusted Odds ratio (95%CI) 
Restricting analysis to only those who underwent 
normal vaginal delivery 
(Total CD=523) 
Adjusted Odds ratio (95%CI) 
Variables  Diagnosed CD 
(n=549) 
Undiagnosed CD 
(n=343) 
Diagnosed CD 
(n=371) 
Undiagnosed CD 
(n=224) 
Postpartum haemorrhage1 1.34 (1.04-1.73) 0.94 (0.62-1.39) 1.22 (0.81-1.84) 0.58 (0.27-1.25) 
Pre-eclampsia/eclampsia1 1.16 (0.66-2.05) 1.24 (0.56-2.75) 0.49 (0.12-2.00) 2.12 (0.83-5.39) 
Antepartum haemorrhage1 1.20 (0.83-1.73) 1.27 (0.80-2.01) 1.36 (0.84-2.20) 1.16 (0.62-2.18) 
Assisted delivery2,6 1.34 (1.05-1.72) 1.01 (0.73-1.40) - - 
Elective caesarean2,6 1.10 (0.82-1.48) 1.38 (0.93-2.04) - - 
Emergency caesarean2,6 1.26 (0.97-1.63) 1.02 (0.72-1.43) - - 
Stillbirth3 1.27 (0.41-3.92) 2.13 (0.69-6.58) 0.65 (0.09-4.63) 1.04 (0.15-7.19) 
Pre-term birth4,6 1.12 (0.78-1.56) 1.29 (0.86-1.93) 0.51 (0.26-0.99) 1.37 (0.80-2.35) 
Low birth weight(<2500 grams)5,6 1.11 (0.73-1.69) 1.43 (0.88-2.32) 0.59 (0.28-1.27) 1.47 (0.76-2.83) 
Adjusted for smoking status, age, ethnicity, diabetes, BMI, social class and calendar year 
1 Analysis based on pregnancy without complication under study  
2Analysis based on normal vaginal delivery 
3Analysis based on live birth 
4Analysis based normal gestational length 
5Analysis based on live birth with normal birth weight 
6Results from multi-nominal regression analysis 
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